about
Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure.Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study.Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years.Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy.The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection.Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B.Long Term Outcomes and Predictive Scores for Hepatocellular Carcinoma and HBsAg Seroclearance after HBeAg Seroclearance.Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong KongLetter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection-authors' replySerum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.A large real-world cohort study examining the effects of long-term entecavir on hepatocellular carcinoma and HBsAg seroclearanceFibrosis evolution in chronic hepatitis B e antigen-negative patients across a 10-year intervalAssociation of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogueHepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinomaEntecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
P50
Q36341736-094361F1-D12E-4D97-B96B-927BEBB30815Q40096029-F522367D-B265-4279-B919-2637B90BA4C4Q40261285-BD9E0FD2-A722-4AB7-909C-00AD999FDE68Q40341578-BE3C0172-E551-4B71-8845-F0135B756321Q40362295-C8859629-2C4F-4138-A049-12D1FB9C3A32Q40404314-B5241744-F5F9-4120-A59B-1765D2A9AFA1Q45326295-07B1B558-777D-4041-AF45-2BA14F802F6EQ47550018-540C8348-2DE9-4EEE-9D27-CE8DF1C9BC9BQ54256777-DF0186AD-FD6D-4530-AB0D-0D4C32DCCEC0Q59357496-CCDFEB68-B406-4286-9BA6-3A6971B464D5Q59359598-AB00DF1F-5FF0-40F7-8E89-C5884547C46CQ65001476-BF6AF12E-0635-4114-BBE6-0A9E126A2D36Q91391041-70F63078-92A5-438D-9E41-1BDA46880F65Q92518178-4B9EBD64-7799-4A59-8F1D-B401B49C577EQ92621523-A53C437D-5231-4170-9AAB-8B4054BB5F9BQ92659305-8A254A73-D0CC-45DF-8D9B-00E3058FD69DQ95839572-86CC3588-5C83-4C73-AD10-C3D30799C50E
P50
description
researcher ORCID ID = 0000-0001-7985-7725
@en
wetenschapper
@nl
name
Man-Fung Yuen
@ast
Man-Fung Yuen
@en
Man-Fung Yuen
@es
Man-Fung Yuen
@nl
type
label
Man-Fung Yuen
@ast
Man-Fung Yuen
@en
Man-Fung Yuen
@es
Man-Fung Yuen
@nl
prefLabel
Man-Fung Yuen
@ast
Man-Fung Yuen
@en
Man-Fung Yuen
@es
Man-Fung Yuen
@nl
P1153
7102031955
P31
P496
0000-0001-7985-7725